Reuters logo
4 months ago
BRIEF-Catalyst Biosciences says milestone payment received with completion of IND-enabling toxicology studies
April 11, 2017 / 12:56 PM / 4 months ago

BRIEF-Catalyst Biosciences says milestone payment received with completion of IND-enabling toxicology studies

1 Min Read

April 11 (Reuters) - Catalyst Biosciences Inc

* Catalyst Biosciences Inc - milestone payment received with completion of IND-enabling toxicology studies

* Catalyst Biosciences - collaborator, isu abxis, plans to initiate a Phase 1/2 proof-of-concept study in individuals with severe Hemophilia B in Q2 of 2017 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below